LBA50 Perioperative nivolumab (NIVO) v placebo (PBO) in patients (pts) with resectable NSCLC: Clinical update from the phase III CheckMate 77T study
| Autor: | Provencio Pulla, M., Awad, M., Cascone, T., Spicer, J.D., He, J., Lu, S., Alexandru, A., Watanabe, Y., Cornelissen, R., Koch, L.D.O., Kuzdzal, J., Pujol, J-L., Hoffknecht, P., Gray, J.E., Coronado Erdmann, C., Neely, J., Devas, V., Bhatia, S., Tanaka, F. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1239-S1240 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|